What's New in Canada?

News

?

Release Date

?

Living with Diabetes During COVID-19 – Canadian T2D Survey Insights

?

?2020.09.09

Type 2 diabetes landscape during COVID-19

?

?2020.09.09

Health Canada approves RYBELSUS? (semaglutide tablets) the first and only GLP-1 analogue in a pill for the treatment of adults with type 2 diabetes

?

?2020.04.08

Novo Nordisk Canada Inc. Response to COVID-19 – Supporting Canadians Living with Diabetes

?

?2020.04.03

Health Canada approves fast-acting mealtime insulin, Fiasp?, for children with diabetes

?

?2020.03.09

Novo Nordisk Canada Inc. recognized as one of Greater Toronto's Top Employers for 2020

?

?2019.12.09

OZEMPIC? is now listed on the Quebec provincial formulary for adults living with type 2 diabetes

?

?2019.11.14

OZEMPIC? is now listed on the Ontario provincial formulary for adults living with type 2 diabetes

?

?2019.09.30

Novo Nordisk Canada announces appointment of new president

?

?2019.09.13

New international study: The hidden burden of diabetes on family members revealed

?

?2019.09.10

OZEMPIC? is now listed on the Alberta provincial formulary for adults living with type 2 diabetes

?

?2019.09.03

ESPEROCT? is now approved in Canada for the Treatment of Hemophilia A in both Children and Adults

?

?2019.07.12

Xultophy? now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes

?

?2019.01.23

Health Canada approves TRESIBA? for children with Type 1 diabetes

?

?2018.10.01

Government of Quebec provides adults living with diabetes mellitus access to ultra-long-acting insulin, TRESIBA?

?

?2018.09.27

Ontario becomes first province to provide public funding of TRESIBA? for adults with diabetes mellitus

?

?2018.09.21

Tresiba? demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo? in real-world evidence study

?

?2018.06.23

Major Partnership set to tackle Diabetes; One of Alberta’s most significant health concerns

?

?2018.06.07

Xultophy? approved in Canada for the treatment of adults with type 2 diabetes

?

?2018.04.18

Novo Nordisk announces the availability of Zonovate? for the treatment of patients with hemophilia A in Quebec

?

?2018.04.11

Novo Nordisk launches Rebinyn?, a new, long-acting treatment for patients with hemophilia B in Canada

?

?2018.04.11

Ozempic? now available for Canadians with type 2 diabetes

?

?2018.03.05

Ozempic? approved in Canada for the treatment of adults with type 2 diabetes

?

?2018.01.09

Health Canada approves Victoza? as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.

?

?2017.11.21

Striking blood sugar balance is critical for Canadians living with diabetes

?

?2017.10.03

Health Canada approves Tresiba?, a new basal insulin for type 1 and 2 diabetes

?

?2017.08.28

Media Advisory - IndyCar Racer Charlie Kimball doesn't let his diabetes take the driver's seat

?

?2017.07.10

Important safety information regarding NovoPen Echo? and NovoPen? 5.

?

?2017.07.10

New fast-acting mealtime insulin, Fiasp?, now approved and available in Canada for the treatment of diabetes

?

?2017.03.27

Vancouver joins with global cities to push for action against urban diabetes

?

?2016.11.14

Study finds Victoza? significantly reduced the risk of heart attack and stroke in people with type 2 diabetes.

?

?2016.06.13

Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRapid? (insulin aspart).

?

?2016.06.13

Saxenda? demonstrated similar efficacy and safety profile across obesity severity stages.

?

?2016.05.03

Global Cities Changing Diabetes Initiative Comes to Vancouver.

?

?2015.12.07

While obesity rates differ among ethnic groups; data shows similar weight loss results using Saxenda?.

?

?2015.12.01

Novo Nordisk Canada secures place on Canada’s Top 100 Employer listing.

?

?2015.11.09

Novo Nordisk announced the availability of Saxenda? (liraglutide) in Canada, the first once-daily human glucagon-like peptide-1 (GLP-1) analogue for chronic weight management in combination with diet and exercise.

?

?2015.08.27

Health Canada and Novo Nordisk Canada review new safety information for repaglinide.

?

?2015.07.31

Appointment Notice - Novo Nordisk Canada Inc.

?

?2015.07.24

The Results are in… Team Novo Nordisk caps off another successful Canadian Visit at Tour de Beauce

?

?2015.06.17

Novo Nordisk receives Health Canada approval for Saxenda? (liraglutide) for the treatment of chronic weight management

?

?2015.02.26

Athlete with type 1 diabetes to finish 7500km run across
Canada in Vancouver on world diabetes day

?

?2014.11.12

Novo Nordisk Canada is pleased to be included in the
"Canada's Top 100 Employers" listing for 2015 announced in a special magazine co-published in the national edition of The Globe and Mail this morning.

?

?2014.11.04

Novo Nordisk Marks 90 Years of Innovating Diabetes CareDenmark's Crown Prince Couple Help Celebrate Canadian, Danish Partnership, Marking Novo Nordisk's 30 Years in Canada

?

?2014.09.18

Québec Becomes First Province to Add Victoza? to the Drug Benefit Formulary* for the Treatment of Type 2 Diabetes

?

?2014.06.04

Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in Tour de Beauce

?

?2014.06.04

Global study: 1 in 4 Canadians with diabetes experience significant emotional distress, 1 in 6 report feelings of discrimination due to their disease

?

?2013.06.24

Canadian biotech industry recognizes top performers

?

?2013.04.22

Families carry a major burden of the diabetes pandemic, according to new results from global study

?

?2012.12.03

Global survey reveals more than a quarter of Canadians with type 2 diabetes do not take insulin as prescribed and one third are experiencing events of low blood sugar frequently.

?

?2012.11.28
免费中文字幕午夜理论,亚洲一日韩欧美中文字幕在线,中文字幕乱视频在线观看